WHO reviewing data on Sanofi dengue vaccine, urges limited use


  • World
  • Tuesday, 05 Dec 2017

GENEVA (Reuters) - The World Health Organization (WHO) said on Monday it hoped to conduct a "full review" by year-end of data on Sanofi's dengue vaccine Dengvaxia.

The Philippines ordered a probe on Monday into the immunisation of more than 730,000 children with the vaccine that has been suspended following an announcement by French drug company that it could worsen the disease in some cases.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

DR Congo accuses Apple of using ‘blood minerals’ from war-torn east
German police swoop on Nigerian dating scammers
74-year-old US woman charged in armed robbery of credit union was scam victim, family says
Australian police charge five teenagers in Sydney cleric's stabbing
Thousands mark Anzac Day in Australia and New Zealand
Spain's Sanchez suspends public duties to 'reflect' on future
How streaming is boosting esports
Brazil's government submits rules to streamline consumption taxes
Roundup: U.S. crude supplies down, other petroleum data mixed
U.S. oil imports, exports up last week

Others Also Read